An Italian multicentre distributed data research network to study the use, effectiveness, and safety of immunosuppressive drugs in transplant patients: Framework and perspectives of the CESIT project
The goal of post-transplant immunosuppressive drug therapy is to prevent organ rejection while minimizing drug toxicities. In clinical practice, a multidrug approach is commonly used and involves drugs with different mechanisms of action, including calcineurin inhibitors (CNI) (tacrolimus or cyclosp...
Saved in:
Similar Items
-
Immunosuppression with Generics in Liver and Kidney Transplantation: A Real-World Evidence Study
by: Finocchietti M, et al.
Published: (2024) -
Palivizumab reimbursement criteria and neonatal RSV hospitalisation: a regional retrospective review
by: Marina Davoli, et al.
Published: (2021) -
Testimonies and experiences of patients awaiting transplant and transplanted patients in Italy: a survey aiming to understand their needs
by: Lia Bellis, et al.
Published: (2023) -
Polytherapy and Multimorbidity Pattern of Users of Anti-VEGF Drugs and Dexamethasone for the Treatment of Age-Related Macular Degeneration and other Vascular Retinopathies in Clinical Practice
by: Ersilia Lucenteforte, et al.
Published: (2023) -
Drug Prescriptions in the Outpatient Management of COVID-19: Evidence-Based Recommendations Versus Real Practice
by: Valeria Belleudi, et al.
Published: (2022)